Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale

Why did Regeneron buy 23andMe for $256M? How will US credit downgrade impact markets? Why is Walmart raising prices due to tariffs? What led JPMorgan to warn about stagflation? How did China respond to US Huawei chip restrictions? Why is Nvidia partnering to scale AI infrastructure? What does the UK-EU post-Brexit reset entail? How will Trump’s tax bill affect the economy? Why is Blink Charging cutting workforce by 20%?

Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale

globenewswire.com/news-release/2025/05/19/3083892/0/en/Regeneron-A-Leading-U-S-Biotechnology-Company-to-Acquire-23andMe-in-Court-Supervised-Sale.html

Regeneron Commits to Comply with Company’s Privacy Policy and All Applicable Law; No Changes to 23andMe’s Privacy Policy or Consumer Genome Services
Transaction Subject to Court Approval
SAN FRANCISCO, May 19, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”)…

This story appeared on globenewswire.com, 2025-05-19 13:08:59.136000.